Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A nano particle vector comprised of poly lactic-co-glycolic acid and monophosphoryl lipid A and recombinant Mycobacterium avium subsp paratuberculosis peptides stimulate a pro-immune profile in bovine macrophages.

Souza CD, Bannantine JP, Brown WC, Norton MG, Davis WC, Hwang JK, Ziaei P, Abdellrazeq GS, Eren MV, Deringer JR, Laws E, Cardieri MCD.

J Appl Microbiol. 2017 Jul;123(1):54-65. doi: 10.1111/jam.13491. Epub 2017 Jun 9.

PMID:
28502107
2.

Identification of a T-Cell Epitope That Is Globally Conserved among Outer Membrane Proteins (OMPs) OMP7, OMP8, and OMP9 of Anaplasma marginale Strains and with OMP7 from the A. marginale subsp. centrale Vaccine Strain.

Deringer JR, Forero-Becerra EG, Ueti MW, Turse JE, Futse JE, Noh SM, Palmer GH, Brown WC.

Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00406-16. doi: 10.1128/CVI.00406-16. Print 2017 Jan.

3.

Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle.

Okagawa T, Konnai S, Deringer JR, Ueti MW, Scoles GA, Murata S, Ohashi K, Brown WC.

Infect Immun. 2016 Sep 19;84(10):2779-90. doi: 10.1128/IAI.00278-16. Print 2016 Oct.

4.

Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.

Zhao L, Mahony D, Cavallaro AS, Zhang B, Zhang J, Deringer JR, Zhao CX, Brown WC, Yu C, Mitter N, Middelberg AP.

PLoS One. 2016 Apr 26;11(4):e0154295. doi: 10.1371/journal.pone.0154295. eCollection 2016.

5.

Nanoparticle-Based Delivery of Anaplasma marginale Membrane Proteins; VirB9-1 and VirB10 Produced in the Pichia pastoris Expression System.

Zhang B, Cavallaro AS, Mody KT, Zhang J, Deringer JR, Brown WC, Mahony TJ, Yu C, Mitter N.

Nanomaterials (Basel). 2016 Nov 5;6(11). pii: E201. doi: 10.3390/nano6110201.

6.

Loss of Immunization-Induced Epitope-Specific CD4 T-Cell Response following Anaplasma marginale Infection Requires Presence of the T-Cell Epitope on the Pathogen and Is Not Associated with an Increase in Lymphocytes Expressing Known Regulatory Cell Phenotypes.

Brown WC, Turse JE, Lawrence PK, Johnson WC, Scoles GA, Deringer JR, Sutten EL, Han S, Norimine J.

Clin Vaccine Immunol. 2015 Jul;22(7):742-53. doi: 10.1128/CVI.00168-15. Epub 2015 Apr 29.

7.

Immunization-induced Anaplasma marginale-specific T-lymphocyte responses impaired by A. marginale infection are restored after eliminating infection with tetracycline.

Turse JE, Scoles GA, Deringer JR, Fry LM, Brown WC.

Clin Vaccine Immunol. 2014 Sep;21(9):1369-75. doi: 10.1128/CVI.00246-14. Epub 2014 Jul 9.

8.

Characterization of a novel microcin that kills enterohemorrhagic Escherichia coli O157:H7 and O26.

Eberhart LJ, Deringer JR, Brayton KA, Sawant AA, Besser TE, Call DR.

Appl Environ Microbiol. 2012 Sep;78(18):6592-9. doi: 10.1128/AEM.01067-12. Epub 2012 Jul 6.

9.

Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.

Deringer JR, Chen C, Samuel JE, Brown WC.

Microbiology. 2011 Feb;157(Pt 2):526-42. doi: 10.1099/mic.0.043513-0. Epub 2010 Oct 28.

10.

Vbeta-dependent stimulation of bovine and human T cells by host-specific staphylococcal enterotoxins.

Deringer JR, Ely RJ, Monday SR, Stauffacher CV, Bohach GA.

Infect Immun. 1997 Oct;65(10):4048-54.

11.

Characterization of the canine type C enterotoxin produced by Staphylococcus intermedius pyoderma isolates.

Edwards VM, Deringer JR, Callantine SD, Deobald CF, Berger PH, Kapur V, Stauffacher CV, Bohach GA.

Infect Immun. 1997 Jun;65(6):2346-52.

12.

Subtype-specific interactions of type C staphylococcal enterotoxins with the T-cell receptor.

Deringer JR, Ely RJ, Stauffacher CV, Bohach GA.

Mol Microbiol. 1996 Nov;22(3):523-34.

PMID:
8939435
13.

Comparison of the beta-toxins from Staphylococcus aureus and Staphylococcus intermedius.

Dziewanowska K, Edwards VM, Deringer JR, Bohach GA, Guerra DJ.

Arch Biochem Biophys. 1996 Nov 1;335(1):102-8.

PMID:
8914839
14.

Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin.

Schlievert PM, Gocke JE, Deringer JR.

Clin Infect Dis. 1993 Jul;17(1):26-31.

PMID:
8353243
15.

Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus.

Lee PK, Kreiswirth BN, Deringer JR, Projan SJ, Eisner W, Smith BL, Carlson E, Novick RP, Schlievert PM.

J Infect Dis. 1992 Jun;165(6):1056-63.

PMID:
1583323
16.

Effect of glycerol monolaurate on bacterial growth and toxin production.

Schlievert PM, Deringer JR, Kim MH, Projan SJ, Novick RP.

Antimicrob Agents Chemother. 1992 Mar;36(3):626-31.

17.

Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells.

Lee PK, Vercellotti GM, Deringer JR, Schlievert PM.

J Infect Dis. 1991 Oct;164(4):711-9.

PMID:
1654356
18.

Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.

Lee PK, Deringer JR, Kreiswirth BN, Novick RP, Schlievert PM.

Infect Immun. 1991 Mar;59(3):879-84.

Supplemental Content

Loading ...
Support Center